These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12763687)

  • 1. Role of complement in the control of HIV dynamics and pathogenesis.
    Stoiber H; Speth C; Dierich MP
    Vaccine; 2003 Jun; 21 Suppl 2():S77-82. PubMed ID: 12763687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement receptors in HIV infection.
    Doepper S; Kacani L; Falkensammer B; Dierich MP; Stoiber H
    Curr Mol Med; 2002 Dec; 2(8):703-11. PubMed ID: 12462391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The supportive role of complement in HIV pathogenesis.
    Stoiber H; Kacani L; Speth C; Würzner R; Dierich MP
    Immunol Rev; 2001 Apr; 180():168-76. PubMed ID: 11414359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
    Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
    Bánki Z; Wilflingseder D; Ammann CG; Pruenster M; Müllauer B; Holländer K; Meyer M; Sprinzl GM; van Lunzen J; Stellbrink HJ; Dierich MP; Stoiber H
    J Immunol; 2006 Sep; 177(5):3469-76. PubMed ID: 16920989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.
    Joling P; Bakker LJ; Van Strijp JA; Meerloo T; de Graaf L; Dekker ME; Goudsmit J; Verhoef J; Schuurman HJ
    J Immunol; 1993 Feb; 150(3):1065-73. PubMed ID: 8423332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-opsonized HIV: the free rider on its way to infection.
    Stoiber H; Pruenster M; Ammann CG; Dierich MP
    Mol Immunol; 2005 Feb; 42(2):153-60. PubMed ID: 15488605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.
    Pruenster M; Wilflingseder D; Bánki Z; Ammann CG; Muellauer B; Meyer M; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2005 Sep; 35(9):2691-8. PubMed ID: 16094691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35).
    Zhou J; Montefiori DC
    Virology; 1996 Dec; 226(1):13-21. PubMed ID: 8941318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner.
    Bouhlal H; Chomont N; Réquena M; Nasreddine N; Saidi H; Legoff J; Kazatchkine MD; Bélec L; Hocini H
    J Immunol; 2007 Jan; 178(2):1086-95. PubMed ID: 17202372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and human complement: inefficient virolysis and effective adherence.
    Bánki Z; Stoiber H; Dierich MP
    Immunol Lett; 2005 Mar; 97(2):209-14. PubMed ID: 15752560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of complement on the surface of cells infected by human immunodeficiency virus.
    Spear GT; Landay AL; Sullivan BL; Dittel B; Lint TF
    J Immunol; 1990 Feb; 144(4):1490-6. PubMed ID: 1968081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative complement pathway activation by CD4+ T cells of HIV infected individuals: a possible role in AIDS pathogenesis.
    Yefenof E; Magyarlaki T; Fenyo EM; Wahren B; Klein E
    Int Immunol; 1994 Sep; 6(9):1361-6. PubMed ID: 7819144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement in HIV infection.
    Stoiber H; Clivio A; Dierich MP
    Annu Rev Immunol; 1997; 15():649-74. PubMed ID: 9143703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement.
    Doepper S; Stoiber H; Kacani L; Sprinzl G; Steindl F; Prodinger WM; Dierich MP
    Immunobiology; 2000 Sep; 202(3):293-305. PubMed ID: 11045664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.
    Wilflingseder D; Banki Z; Garcia E; Pruenster M; Pfister G; Muellauer B; Nikolic DS; Gassner C; Ammann CG; Dierich MP; Piguet V; Stoiber H
    J Immunol; 2007 Jun; 178(12):7840-8. PubMed ID: 17548622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naïve and treated HIV-1 infected individuals: Correlation with immune activation status.
    Mishra N; Mohata M; Aggarwal H; Chaudhary O; Das BK; Sinha S; Hazarika A; Luthra K
    Mol Immunol; 2018 Apr; 96():83-87. PubMed ID: 29525453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
    Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
    J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to the HIV-1 V3 loop in serum from infected persons contribute a major proportion of immune effector functions including complement activation, antibody binding, and neutralization.
    Spear GT; Takefman DM; Sharpe S; Ghassemi M; Zolla-Pazner S
    Virology; 1994 Nov; 204(2):609-15. PubMed ID: 7941328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.